Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.14.5 extracted from

  • Deacon, C.F.; Holst, J.J.
    Dipeptidyl peptidase IV inhibitors: a promising new therapeutic approach for the management of type 2 diabetes (2006), Int. J. Biochem. Cell Biol., 38, 831-844.
    View publication on PubMed

Application

Application Comment Organism
medicine dipeptidyl peptidase IV inhibitors are a promising new therapeutic approach for the management of type 2 diabetes Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-